Epstein-Barr virus is absent in gastric superficial neoplastic lesions.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 16 04 2019
accepted: 22 09 2019
revised: 19 09 2019
pubmed: 2 11 2019
medline: 21 12 2019
entrez: 2 11 2019
Statut: ppublish

Résumé

Epstein-Barr virus (EBV) has been associated with about 9% of all gastric carcinomas, but its role in gastric carcinogenesis remains unclear since there is lack of evidence of EBV presence in pre-neoplastic lesions of gastric mucosa. This study intends to determine the prevalence of EBV in gastric dysplasia and superficial neoplasia to clarify whether EBV infection is an early or late event in gastric cancer development. This retrospective study included a total of 242 gastric lesions from 199 consecutive patients who were referred for endoscopic resection. The histological classification of lesions includes 137 low- and high-grade dysplasia and 105 superficial carcinomas. EBV infection was investigated by EBER-ISH. Results showed that EBV was not detected in any epithelial cells of any case with dysplasia or superficial carcinomas, although we observed the presence of a small number of EBV-infected lymphocytes in 2.1% of all lesions. These results showed that EBV is not present in gastric dysplasia neither in superficial carcinomas suggesting that EBV carcinogenesis is a late event in well/moderately differentiated gastric carcinogenesis.

Identifiants

pubmed: 31673776
doi: 10.1007/s00428-019-02670-1
pii: 10.1007/s00428-019-02670-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

757-762

Références

J Clin Pathol. 2004 May;57(5):487-91
pubmed: 15113855
World J Gastroenterol. 2017 Oct 28;23(40):7292-7302
pubmed: 29142476
Hum Pathol. 1996 Jan;27(1):20-7
pubmed: 8543306
Microsc Res Tech. 2001 Jun 15;53(6):409-13
pubmed: 11525258
J Gastroenterol Hepatol. 2009 Mar;24(3):354-65
pubmed: 19335785
Int J Gastrointest Cancer. 2003;34(2-3):87-94
pubmed: 15361640
Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1003-8
pubmed: 18192401
Gut. 2002 Jul;51(1):130-1
pubmed: 12077106
J Med Microbiol. 2006 Jul;55(Pt 7):905-11
pubmed: 16772418
Oncol Rep. 2001 Sep-Oct;8(5):995-9
pubmed: 11496304
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Int J Cancer. 2010 Oct 1;127(7):1570-83
pubmed: 20091869
Mod Pathol. 1990 May;3(3):377-80
pubmed: 2163534
Br J Cancer. 2011 Jun 28;105(1):38-43
pubmed: 21654677
Cancer Lett. 2017 Sep 28;404:37-43
pubmed: 28729047
Viruses. 2014 Jan 20;6(1):301-18
pubmed: 24448220
Infect Agent Cancer. 2017 Jul 19;12:41
pubmed: 28814970
Am J Pathol. 1993 Nov;143(5):1250-4
pubmed: 8238241
Am J Surg Pathol. 2007 Sep;31(9):1446-51
pubmed: 17721202
Nature. 2014 Sep 11;513(7517):202-9
pubmed: 25079317
World J Gastroenterol. 2014 Apr 14;20(14):3916-26
pubmed: 24744581
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:42-5
pubmed: 21199513
Eur J Surg Oncol. 2014 May;40(5):584-591
pubmed: 24685156
Dig Endosc. 2018 Sep;30(5):667-671
pubmed: 29729036
Gut. 2014 Feb;63(2):236-43
pubmed: 23580779
Nat Rev Cancer. 2016 Dec;16(12):789-802
pubmed: 27687982
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
Mol Pathol. 2000 Oct;53(5):255-61
pubmed: 11091849
J Pathol. 1997 Nov;183(3):293-8
pubmed: 9422984
Endoscopy. 2012 Jan;44(1):74-94
pubmed: 22198778
BMC Gastroenterol. 2014 Oct 15;14:179
pubmed: 25318991
Viruses. 2012 Dec;4(12):3420-39
pubmed: 23342366
Am J Surg Pathol. 1996 Oct;20(10):1161-81
pubmed: 8827022
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):E3473-82
pubmed: 23161911
Helicobacter. 2016 Apr;21(2):153-7
pubmed: 26251258

Auteurs

Joana Ribeiro (J)

Molecular Oncology & Viral Pathology Group (CI-IPOP), Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. joana.cribeiro@hotmail.com.
Faculty of Medicine of Porto University, FMUP, Rua Al. Prof Hernâni Monteiro, 4200-072, Porto, Portugal. joana.cribeiro@hotmail.com.

Mariana Malta (M)

Molecular Oncology & Viral Pathology Group (CI-IPOP), Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
Research Department, Portuguese League Against Cancer (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte), Estrada interior da Circunvalação 6657, 4200-172, Porto, Portugal.

Ana Galaghar (A)

Department of Pathology, Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.

Luís Pedro Afonso (LP)

Department of Pathology, Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.

Diogo Libânio (D)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
CINTESIS - Center for Health Technology and Services Research (Centro de Investigação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.

Rui Medeiros (R)

Molecular Oncology & Viral Pathology Group (CI-IPOP), Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
Research Department, Portuguese League Against Cancer (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte), Estrada interior da Circunvalação 6657, 4200-172, Porto, Portugal.
Virology Service, Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.

Mario Dinis-Ribeiro (M)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
CINTESIS - Center for Health Technology and Services Research (Centro de Investigação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.

Pedro Pimentel-Nunes (P)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
CINTESIS - Center for Health Technology and Services Research (Centro de Investigação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.

Hugo Sousa (H)

Molecular Oncology & Viral Pathology Group (CI-IPOP), Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. hugo.sousa@ipoporto.min-saude.pt.
Faculty of Medicine of Porto University, FMUP, Rua Al. Prof Hernâni Monteiro, 4200-072, Porto, Portugal. hugo.sousa@ipoporto.min-saude.pt.
Virology Service, Portuguese Oncology Institute of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. hugo.sousa@ipoporto.min-saude.pt.
Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal. hugo.sousa@ipoporto.min-saude.pt.
ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal. hugo.sousa@ipoporto.min-saude.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH